BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$18.03 USD
-0.13 (-0.72%)
Updated May 3, 2024 04:00 PM ET
After-Market: $18.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Brokerage Reports
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 1 - 20 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
3Q23 as Expected with Asset Sale into 2024
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
CEO Change to Long-Time Operator Seems Like Efficient Pathway to Value Creation
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2Q23 - Pro Forma Look Cell Therapy Pure Play in 2024-2025
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Cryoport Lowers Guidance: Implications for CGT Players
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
1Q Light, but Freeze Thaw ''Strategic Review'' Very Positive Move
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
4Q22 - Margin Expansion Comes into Clear View
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Risk Factors for Life Science May Be de Minimis
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
JPM Takeaways, Positive Industry Backdrop for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Positive Announcements Rolling Out at JPM
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department